{"title":"Distribution and Antibiotic Resistance Analysis of 13,048 Clinically Common Isolates.","authors":"Jing Zhao, Peng Yue, Zhi-Jie Li, Ting Xu, Guo-Zheng Xing, Yan Shao, Hong-Yuan Yu","doi":"10.2147/IDR.S510193","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study investigated the distribution and antibiotic resistance profiles of common bacteria isolated from clinical specimens at a hospital's microbiology laboratory between 2020 and 2022.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on microbial culture results from clinical specimens collected over three years, including sample types, departmental distribution, pathogen species, and resistance profiles.</p><p><strong>Results: </strong>A total of 13,048 unique pathogenic strains were isolated, predominantly from respiratory and urine specimens. Secretion specimens exhibited the highest positive detection rate (73.6%), while blood specimens showed a lower rate (9.7%). The five most frequently isolated pathogens were: <i>Klebsiella pneumoniae</i> (<i>K. pneumoniae</i>) (19.6%), <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) (14.7%), <i>Escherichia coli</i> (<i>E. coli</i>) (9.2%), <i>Acinetobacter baumannii</i> (<i>A. baumannii</i>) (8.0%), and <i>Candida albicans</i> (<i>C. albicans</i>) (7.0%). Gram-negative bacteria constituted 53.7% of all isolates (7009/13,048). A total of 7590 multidrug-resistant organisms (MDRO) were identified, corresponding to a detection rate of 21.3% (7590/35,613). The detection rates of carbapenem-resistant Enterobacteriaceae (CRE) increased annually: 7.2% (2020), 8.6% (2021), and 14.4% (2022).</p><p><strong>Conclusion: </strong>The annual detection rate of CRE increased during the study period, while the rate of <i>methicillin-resistant Staphylococcus aureus</i> (MRSA) declined. Timely and effective interventions targeting pathogenic bacteria are essential for controlling and mitigating nosocomial infection risks.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"1071-1081"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869759/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S510193","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study investigated the distribution and antibiotic resistance profiles of common bacteria isolated from clinical specimens at a hospital's microbiology laboratory between 2020 and 2022.
Methods: A retrospective analysis was conducted on microbial culture results from clinical specimens collected over three years, including sample types, departmental distribution, pathogen species, and resistance profiles.
Results: A total of 13,048 unique pathogenic strains were isolated, predominantly from respiratory and urine specimens. Secretion specimens exhibited the highest positive detection rate (73.6%), while blood specimens showed a lower rate (9.7%). The five most frequently isolated pathogens were: Klebsiella pneumoniae (K. pneumoniae) (19.6%), Pseudomonas aeruginosa (P. aeruginosa) (14.7%), Escherichia coli (E. coli) (9.2%), Acinetobacter baumannii (A. baumannii) (8.0%), and Candida albicans (C. albicans) (7.0%). Gram-negative bacteria constituted 53.7% of all isolates (7009/13,048). A total of 7590 multidrug-resistant organisms (MDRO) were identified, corresponding to a detection rate of 21.3% (7590/35,613). The detection rates of carbapenem-resistant Enterobacteriaceae (CRE) increased annually: 7.2% (2020), 8.6% (2021), and 14.4% (2022).
Conclusion: The annual detection rate of CRE increased during the study period, while the rate of methicillin-resistant Staphylococcus aureus (MRSA) declined. Timely and effective interventions targeting pathogenic bacteria are essential for controlling and mitigating nosocomial infection risks.
期刊介绍:
About Journal
Editors
Peer Reviewers
Articles
Article Publishing Charges
Aims and Scope
Call For Papers
ISSN: 1178-6973
Editor-in-Chief: Professor Suresh Antony
An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.